Director, Medical Economics/Medical Expense Actuary
Devoted HealthSalary not specified
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Technology, Healthcare Services, Health EconomicsIndustries
Requirements
Candidates should possess a Master's degree in a relevant field such as Health Economics, Public Health, Business Administration, or a related discipline, and demonstrate a minimum of 10 years of experience in health economics and market access strategy, with a strong preference for experience in the medical device or healthcare technology industry. Experience in developing and executing market access strategies, conducting health economic analyses, and engaging with payers and stakeholders is highly desirable.
Responsibilities
The Vice President of Health Economics and Access Strategy will develop and execute a comprehensive health economics and market access strategy for HeartFlow’s product portfolio, driving cost-effectiveness analyses and securing coding, coverage, and payment through engagement with key stakeholders including providers, payers, and government agencies. They will lead market access initiatives, design communication tools to articulate the clinical and economic value of HeartFlow’s technologies, and drive evidence generation strategies to strengthen the company’s value proposition with policymakers and regulatory bodies, collaborating closely with the SVP of Market Access and Reimbursement and internal teams.
Skills
Health Economics
Market Access Strategy
Coding and Reimbursement
Stakeholder Engagement
Healthcare Policy
Strategic Planning
HeartFlow
Non-invasive cardiac testing for heart disease
About HeartFlow
HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.
Key Metrics
Redwood City, CaliforniaHeadquarters
2010Year Founded
$858.5MTotal Funding
SERIES_FCompany Stage
HealthcareIndustries
501-1,000Employees